HRT Financial’s Labcorp LH Stock Holding History

HRT Financial’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,269	Closed	-$6.11M	–	3307
2025 Q2	$6.11M	Buy	+23,269	New	+$5.67M	0.03%	456
2024 Q1	–	Sell	-76,464	Closed	-$17.4M	–	2739
2023 Q4	$17.4M	Buy	+76,464	New	+$16.1M	0.13%	89
2023 Q2	–	Sell	-2,044	Closed	-$402K	–	2898
2023 Q1	$402K	Buy	+2,044	New	+$421K	﹤0.01%	1536
2022 Q4	–	Sell	-61,794	Closed	-$10.9M	–	2839
2022 Q3	$10.9M	Buy	+61,794	New	+$12.7M	0.12%	129
2022 Q1	–	Sell	-4,861	Closed	-$1.31M	–	3503
2021 Q4	$1.31M	Buy	4,861 +2,734	+129%	+$677K	0.01%	915
2021 Q3	$514K	Buy	+2,127	New	+$536K	﹤0.01%	1941
2020 Q3	–	Sell	-7,401	Closed	-$1.06M	–	2157
2020 Q2	$1.06M	Buy	+7,401	New	+$1.02M	0.03%	531
2019 Q3	–	Sell	-30,087	Closed	-$4.47M	–	1506
2019 Q2	$4.47M	Buy	30,087 +27,758	+1,192%	+$3.87M	0.28%	82
2019 Q1	$306K	Buy	+2,329	New	+$287K	0.05%	290

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

HRT Financial's LH Position: Q3 2025 in Review

HRT Financial sold out of Labcorp (LH) in Q3 2025, closing a stake of 23,269 shares — an estimated $6.11M sold.

HRT Financial first reported a position in LH in Q1 2019 and held it in 9 quarters. The position peaked at $17.4M in Q4 2023. 1,012 funds tracked by Wall St. Rank hold LH as of Q3 2025.

HRT Financial reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
HRT Financial sold 23,269 Labcorp shares in Q3 2025, an estimated $6.11M.
HRT Financial first reported a position in Labcorp in Q1 2019 and held it in 9 quarters.
HRT Financial's Labcorp position peaked at $17.4M in Q4 2023.
1,012 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.